Overview
Indications
2 2 XENICAL is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. XENICAL is also indicated to reduce the risk for weight regain after prior weight loss. XENICAL is indicated for obese patients with an initial body mass index (BMI) ≥30 kg/mor ≥27 kg/min the presence of other risk factors (e.g., hypertension, diabetes, dyslipidemia). Table 1 ' " illustrates body mass index (BMI) according to a variety of weights and
Contraindications
When this intervention should not be used
XENICAL is contraindicated in: Use in Specific Populations (8.1) [see] Pregnancy Patients with chronic malabsorption syndrome Patients with cholestasis Patients with known hypersensitivity to XENICAL or to any component of this product
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
Clinical Trials
426 trials linked to this intervention
Recent Trials
Diabetes and Heart Disease Risk in Blacks
Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat
Pediatric Hypothalamic Obesity
The Safety and Effectiveness of Low and High Carbohydrate Diets
Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Specialists
Providers who commonly manage this intervention
Family Medicine — Obesity Medicine
NUCC 207QB0002XInternal Medicine — Obesity Medicine
NUCC 207RB0002XInternal Medicine — Endocrinology, Diabetes & Metabolism
NUCC 207RE0101XHealth Goals
Goals connected through associated conditions
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Orlistat (substance)
- SNOMED CT
- 387007000
- UMLS CUI
- C0076275
- RxNorm CUI
- 37925
- Labeler
- H2-Pharma LLC
Clinical Data
This intervention maps to 9 entities in the Ltrl knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.